VANCOUVER, BC, July 10,
2024 /CNW/ - Numinus Wellness Inc. ("Numinus" or
the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health
care company advancing traditional and innovative behavioural
health treatments with a focus on safe, evidence-based
psychedelic-assisted therapies, will release its financial results
for the quarter ended May 31, 2024, after market close
on Thursday, July 11, 2024.
Interested parties are invited to participate in the Company's
Q3 2024 results conference call and webcast, which will be held on
the same day at 5:30 p.m. Eastern time / 2:30 p.m.
Pacific time. During the call, Numinus executives will review the
Company's performance and recent initiatives.
A question-and-answer session will follow management's prepared
remarks. At this time, the operator will provide instructions for
qualified equity analysts to submit questions. Investors are
invited to submit questions by email to invest@numinus.com. A
selection of questions will be answered by management on the call,
and all emailed questions will be responded to by email.
To listen to the live webcast, please register at:
https://events.q4inc.com/attendee/881868667
The webcast will also be archived on the Events and
Presentations page of Numinus' Investor Relations website:
https://www.investors.numinus.com/events-and-presentations/
To participate in the live conference call, please use the
following dial-in information:
- 1 (888) 330-3632 (Toll-free North America)
- 1 (646) 960-0837 (International)
- Ask to participate in Numinus' Q3 2024 Results Call
To avoid any delays in joining the call, please dial in at least
five minutes before the call starts. If prompted, please provide
conference passcode 3547386.
About Numinus
Numinus Wellness Inc. (TSX: NUMI)
(OTCQX: NUMIF) helps people to heal and be well through the
development and delivery of innovative mental health care and
access to safe, evidence-based psychedelic-assisted therapies. The
Numinus model – including psychedelic research and clinic care – is
at the forefront of a transformation aimed at healing rather than
managing symptoms for depression, anxiety, trauma, pain and
substance use. At Numinus, we are leading the integration of
psychedelic-assisted therapies into mainstream clinical practice
and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us
on LinkedIn, Facebook, Twitter,
and Instagram.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/numinus-to-host-q3-fiscal-2024-results-conference-call-on-july-11-2024-302194165.html
SOURCE Numinus Wellness Inc.